Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illinois Tool Works Inc. (ITW) vs GeneDx Holdings Corp (WGS) Price & Performance

Illinois Tool Works Inc.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Illinois Tool Works Inc. vs GeneDx Holdings Corp — how do they compare? Illinois Tool Works Inc. trades at $262.75 (market cap $74.38B), while GeneDx Holdings Corp trades at $67.92 (market cap $2.02B). The key difference: Illinois Tool Works Inc. is far larger — about 36.8× GeneDx Holdings Corp's market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and GeneDx Holdings Corp for 19 Days on average.

ITWWGS
Market Cap
$74.38B$2.02B
Volume
1,125,477734,640
Sector
IndustrialsHealth
52-Week High
$299.60$167.51
52-Week Low
$241.07$34.51
Typical Hold Time
67 Days19 Days
Enterprise Value
$83.23B$2.05B
Dividend Yield
2.63%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illinois Tool Works Inc.

ITW trades at $261.15, down 2.24% on the day, with technical indicators showing bearish momentum as the stock tests support near $261. The company maintains strong fundamentals with a 19.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights ITW's dividend increase to $1.72 per share, reinforcing its status as a Dividend King with 59 years of consecutive increases.

The outlook remains mixed with solid profitability offset by bearish technicals. Upside potential exists toward the $276.86 analyst consensus target, but investors face headwinds from weak technical momentum and mixed analyst sentiment where only 21% recommend buying. Key risks include debt levels rising to 55.54% of assets and exposure to cyclical industrial demand.

GeneDx Holdings Corp

GeneDx (WGS) trades at $68.50, down 0.04% with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue of $114.4M beating expectations but net income margin remains negative at -23.4%. Recent developments include new product launches and positive analyst coverage with 91% buy ratings.

While analyst consensus targets $81.00 (18% upside), fundamental challenges persist with negative profitability metrics and high valuation multiples. The stock faces execution risks amid competitive genomics landscape, but operational improvements and testing volume growth provide potential catalysts for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITW
75% Buy25% Sell
Avg holding period · 67 Days
WGS
53% Buy47% Sell
Avg holding period · 19 Days

Top news

Latest headlines on both assets

About Illinois Tool Works Inc.

Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.

Read more on ITW →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →